Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 15, 2022 - Issue
Submit an article Journal homepage
117
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Antibiotic Treatment for Hidradenitis Suppurativa in France: A Practice Survey

Anne-Claire Fougerousse1 Dermatology Department, Military Teaching Hospital Bégin, Saint Mandé, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2850-867X
ORCID Icon,
François Maccari1 Dermatology Department, Military Teaching Hospital Bégin, Saint Mandé, France;2 Dermatology, Private Practice, Saint-Maur-des-Fossés, France
,
Philippe Guillem3 Visceral Surgery department, Clinique du Val d’Ouest, Ecully, France
&
Ziad Reguiai4 Dermatology Department, Polyclinique Courlancy-Bezannes, Reims, France
Pages 2641-2645 | Received 04 Jul 2022, Accepted 13 Oct 2022, Published online: 08 Dec 2022

References

  • Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22(5):325–328. doi:10.1111/j.1365-4362.1983.tb02150.x
  • Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39(6):971–974. doi:10.1016/S0190-9622(98)70272-5
  • Gener G, Canoui-Poitrine F, Revuz JE, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219(2):148–154. doi:10.1159/000228334
  • Iannone M, Janowska A, Bartolomei G, et al. Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther. 2021;34(3):e14919. doi:10.1111/dth.14919
  • Mendonça CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol. 2006;154(5):977–978. doi:10.1111/j.1365-2133.2006.07155.x
  • van der Zee HH, Boer J, Prens EP, Jemec GB. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology. 2009;219(2):143–147. doi:10.1159/000228337
  • Bettoli V, Zauli S, Borghi A, et al. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. J Eur Acad Dermatol Venereol. 2014;28(1):125–126. doi:10.1111/jdv.12127
  • Dessinioti C, Zisimou C, Tzanetakou V, Stratigos A, Antoniou C. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up. Clin Exp Dermatol. 2016;41(8):852–857. doi:10.1111/ced.12933
  • Yao Y, Jørgensen AR, Ring HC, Thomsen SF. Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study. Br J Dermatol. 2021;184(3):552–553. doi:10.1111/bjd.19578
  • Rosi E, Pescitelli L, Ricceri F, et al. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa. Dermatol Ther. 2019;32(2):e12792. doi:10.1111/dth.12792
  • Delaunay J, Villani AP, Guillem P, Tristan A, Boibieux A, Jullien D. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients. Br J Dermatol. 2018;178(1):e15–e16. doi:10.1111/bjd.15739
  • Delage M, Jais JP, Lam T, et al. Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley Stage 1 Hidradenitis Suppurativa: prospective short-term trial and one-year follow-up in 28 consecutive patients. J Am Acad Dermatol. 2020. doi:10.1016/j.jaad.2020.01.007
  • Yazdanyar S, Boer J, Ingvarsson G, Szepietowski JC, Jemec GB. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. Dermatology. 2011;222(4):342–346. doi:10.1159/000329023
  • Bertolotti A, Sbidian E, Join-Lambert O, et al. Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology. Br J Dermatol. 2021;184(5):963–965. doi:10.1111/bjd.19710
  • Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619–644. doi:10.1111/jdv.12966

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.